A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
This is a non-randomized Phase 2 study testing pemetrexed and doxorubicin in combination for
locally advanced or metastatic breast cancer. Both pemetrexed and doxorubicin have been
combined with other drugs, but they have not yet been combined with each other. It is
expected that the patient will benefit from the different mechanisms of action of the two
drugs. However, there is no guarantee that the patient will benefit from this treatment.